 Rationalisation follow-up patients non-invasive bladder tumours preliminary report risk recurrence progression patients pTa urothelial tumours bladder follow-up Patients years original pathology carcinoma situ CIS dysplasia background urothelium patients whole follow-up period overall progression rate Solitary tumours annual initial recurrence risk AIR first year first year AIR subsequent years years patients multiple tumours recurrences first year AIR grade recurrence progression results solitary pTa tumours frequent endoscopic follow-up justified surveillance disease-free years necessary risk recurrence useful factor follow-up